Al Gore's Strategic Moves in Q3 2024: Spotlight on Agilent Technologies with a 2.1% Portfolio Impact
In This Article:
Insights into Generation Investment Management's Latest 13F Filing
Al Gore (Trades, Portfolio)'s investment firm, Generation Investment Management, has recently disclosed its 13F filing for the third quarter of 2024, revealing significant portfolio adjustments and strategic entries into new stocks. Founded in 2004 by Al Gore (Trades, Portfolio) and David Blood, the firm is renowned for its commitment to long-term investments that emphasize sustainability and ethical governance. Operating from London with additional offices globally, Generation Investment Management focuses on integrating sustainability research into its investment decisions, targeting sectors like information technology, healthcare, finance, and industrials.
Summary of New Buys
During the third quarter of 2024, Al Gore (Trades, Portfolio)'s firm made notable new investments in several companies:
-
Agilent Technologies Inc (NYSE:A) emerged as the primary new holding, with 3,034,247 shares valued at approximately $450.53 million, making up 2.1% of the portfolio.
-
Visa Inc (NYSE:V) was another significant addition, with 829,255 shares worth around $228.00 million, accounting for about 1.07% of the portfolio.
Key Position Increases
The firm also increased its stakes in several existing holdings:
-
Workday Inc (NASDAQ:WDAY) saw a substantial increase of 1,114,040 shares, bringing the total to 1,471,667 shares. This adjustment marks a 311.51% rise in share count and a 1.27% impact on the current portfolio, valued at $359.69 million.
-
Charles Schwab Corp (NYSE:SCHW) also experienced a significant boost with an additional 3,605,768 shares, making a total of 12,179,766 shares, a 42.05% increase in share count, valued at $789.37 million.
Summary of Sold Out Positions
Al Gore (Trades, Portfolio) completely exited positions in several companies:
-
Carlisle Companies Inc (NYSE:CSL) was completely sold off with 718,923 shares, impacting the portfolio by -1.4%.
-
10x Genomics Inc (NASDAQ:TXG) saw all 2,884,661 shares liquidated, affecting the portfolio by -0.27%.
Key Position Reductions
Significant reductions were made in the following stocks:
-
Equifax Inc (NYSE:EFX) was reduced by 1,555,553 shares, a 42.99% decrease, impacting the portfolio by -1.81%. The stock traded at an average price of $282.04 during the quarter and has seen a -10.82% return over the past three months and a 7.22% year-to-date return.
-
Henry Schein Inc (NASDAQ:HSIC) saw a reduction of 4,845,933 shares, a 52.39% decrease, impacting the portfolio by -1.49%. The stock traded at an average price of $69.33 during the quarter and has returned -2.38% over the past three months and -11.66% year-to-date.